US and UK provide defensive security assistance to Ukraine
The US has reportedly confirmed that it authorised an additional $200m in defensive military assistance for Ukraine last month. An…
All articles by Himaja Ganta
Himaja Ganta
-
-
Russia conducts military drills amid tensions with Ukraine
Russia has reportedly started military training exercises, in the southwestern part of the country, amid ongoing tensions with neighbouring country…
-
Biotechnology company Rakuten Medical acquires Medlight
Global biotechnology firm Rakuten Medical has announced the acquisition of Swiss medical company Medlight SA. Medlight is a producer of…
-
US company Aerin Medical announces closing of $48m equity financing
Medical device company Aerin Medical has announced the closing of a $48m equity financing. The financing round was led by…
-
J&J’s Biosense received CE Mark for QDOT MICRO ablation catheter
Biosense Webster, a subsidiary of Johnson & Johnson Medical Devices Companies, has received European CE mark approval for the QDOT…
-
RadNet and Hologic partner on AI tools development for breast health
Imaging services provider RadNet and diagnostic products developer Hologic have agreed to collaborate on developing artificial intelligence (AI) tools for breast health. According to…
-
BD receives order for 177 million needles and syringes
Medical device maker Becton, Dickinson and Company (BD) has received additional orders from the US and Canada governments for 177…
-
Ortho receives CE mark for second Covid-19 antibody test
In-vitro diagnostics developer Ortho Clinical Diagnostics has received the CE mark for its Vitros Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test, also…
-
FDA approves CivaTech’s oncology therapy product CivaDerm
The US Food and Drug Administration (FDA) has approved medical technology company CivaTech Oncology’s temporary radiation therapy product CivaDerm. CivaDerm…
-
Senseonics completes patient enrolment in PROMISE clinical trial
Medical technology firm Senseonics has completed patient enrolment in the Eversense PROMISE 180-day sensor clinical study of Eversense continuous glucose…